Choosing Between Continuing Vitamin K Antagonists (VKA) or Switching to a Direct Oral Anticoagulant in Currently Well-Controlled Patients on VKA for Atrial Fibrillation: A Randomised Controlled Trial (GAInN)

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15856

Related search